Pfizer and BioNTech provided EU more than 200 million additional doses of COMIRNATY for vaccine supply
On Dec. 20, 2021, Pfizer and BioNTech announced an agreement had been reached with the European Commission (EC)…
Moderna announced preliminary booster data and updated strategy to address Omicron variant
On Dec. 20, 2021, Moderna announced preliminary neutralizing antibody data against the Omicron variant following the Company’s booster…
Oragenics extended collaboration with the National Research Council of Canada (NRC) to develop vaccine against Omicron variant
On Dec. 20, 2021, Oragenics announced it had extended a licensing and collaboration agreement with the National Research…
Novavax and Serum Institute of India announced WHO Emergency Use listing for NVX-CoV2373 COVID-19 vaccine
On Dec. 17, 2021, Novavax and SK bioscience announced that the World Health Organization had granted Emergency Use…
NIH scientists urged pursuit of universal coronavirus vaccine
On Dec. 16, 2021, NIH scientists announced that to counter future coronavirus outbreaks, the global scientific and medical…
Johnson & Johnson announced positive CHMP opinion for a booster shot of its COVID-19 vaccine
On Dec. 15, 2021, Johnson & Johnson announced that the Committee for Medicinal Products for Human Use (CHMP)…
Novavax announced submission of New Drug Application in Japan for approval of COVID-19 vaccine
On Dec. 15, 2021, Novavax announced the submission of a New Drug Application to the Ministry of Health,…
Military Health System marked 1-year anniversary for COVID vaccinations
One year ago, on Dec. 14, 2020, the Military Health System began administering the first COVID-19 vaccine shots….
Moderna and Australia announced collaboration to bring mRNA manufacturing to Australia
On Dec. 13, 2021, Moderna announced an agreement with the Australian Government to build a state-of-the-art messenger RNA…
Novavax filed for Emergency Use of COVID-19 vaccine in the United Arab Emirates
On Dec. 13, 2021, Novavax announced that it has submitted a regulatory filing to the Ministry of Health…
CEPI partnered with Affinivax to develop a novel COVID-19 vaccine to target variants
On Dec. 13, 2021, the Coalition for Epidemic Preparedness Innovations, and Affinivax announced a partnership to advance the…
Moderna announced additional 20 million doses of COVID-19 vaccine to COVAX for supply in 2021 and additional supply for 2022
On Dec. 10, 2021, Moderna announced an amendment to its existing contract with Gavi, the Vaccine Alliance, to…
Biotechnology | COVID-19 | Life Science News | Vaccine | WHO
World Health Organization announced interim recommendations for use of the Janssen Ad26.COV2.S vaccine
On Dec. 10, 2021, the World Health Organization announced interim recommendations for the use of the Janssen Ad26.COV2.S…
Artificial Intelligence | Biotechnology | COVID-19 | Infectious Disease | Life Science News | Vaccine
Moderna launched AI Academy in partnership with Carnegie Mellon University
On Dec. 9, 2021, Moderna announced the launch of its Artificial Intelligence Academy, an innovative initiative that will…
Pfizer and BioNTech provided update on Omicron variant
On Dec. 8, 2021, Pfizer and BioNTech announced results from an initial laboratory study demonstrating that serum antibodies…
USAID announced Initiative for Global Vaccine Access to accelerate vaccine access and delivery around the world
On Dec. 6, 2021, the USAID announced the foundation of a new whole-of-government effort, the Initiative for Global…
Sorrento announced publication of novel SARS-CoV-2 main protease inhibitors for potential treatment of COVID-19 patients infected with SARS-CoV-2
On Dec. 5, 2021, Sorrento Therapeutics announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors…
Johnson & Johnson COVID-19 booster showed substantial increase in antibody and T-cell responses
On Dec. 5, 2021, Johnson & Johnson announced preliminary results from an independent study, including a subset of…
Gavi approved malaria vaccine programme funding
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
Resilience and Harvard University announced five-year R&D alliance to incubate new technologies
On Dec. 2, 2021, National Resilience and Harvard University announed they had established a five-year research and development…
Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023
On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…
INOVIO Announced Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Life Science History | Medicine | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 roller coaster
The COVID-19 Roller Coaster is a wild ride, strap yourself in and hold on… Cast of Characters: Senator…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
Merck and Ridgeback Biotherapeutics provided update on results from MOVe-OUT study of Molnupiravir in adults with COVID-19
On Nov. 26, 2021, Merck provided an update on the MOVe-OUT study of molnupiravir, an investigational oral antiviral…
Pfizer and BioNTech received positive CHMP opinion for COMIRNATYï¾® in children 5 to under 12 years of age in the EU
On Nov. 25, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
Novavax filed for interim authorization of COVID-19 vaccine in singapore
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in ages 18 years and older
On Nov. 24, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration had issued Emergency Use…
WHO and Medicines Patent Pool announced first transparent, global, non-exclusive licence for COVID-19 technology
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
Follow-up data from phase 3 trial of Pfizer-BioNTech COVID-19 vaccine supported safety and high efficacy in adolescents 12 through 15 years of age
On Nov. 22, 2021, Pfizer announced topline results from a longer-term analysis of the safety and efficacy of…
India completed national introduction of pneumococcal conjugate vaccine
On Nov. 21, 2021, Gavi, the Vaccine Alliance, announced that India has completed the national introduction of pneumococcal…